New York: Novo Nordisk has secured the US Food and Drug Administration (US FDA)’s approval for the pill version of its blockbuster weight loss drug Wegovy, giving the Danish pharmaceutical...
New Delhi: The blockbuster weight loss drug Ozempic is all set to get an Indian generic variant, with the Delhi HC refusing to stop Dr Reddy’s from exporting a generic...
New York: A new player has emerged in the almost $300 billion weight loss market. Following Ozempic’s exploding popularity as a quick weight loss treatment and Wegovy and other drugs...
New Delhi: Pfizer just pulled off a $10 billion masterstroke. After a week of boardroom chaos and regulatory warnings, the US pharma giant beat Novo Nordisk to acquire weight-loss start-up...
Mumbai: The widely popular weight loss drug, Ozempic, has been approved by the Central Drugs Standard Control Organisation (CDSCO) for use in India. Developed by Danish drugmaker Novo Nordisk, Ozempic...
